136 related articles for article (PubMed ID: 1371665)
41. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J
Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904
[TBL] [Abstract][Full Text] [Related]
42. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
43. Effect of nitric oxide gas on platelets during open heart operations.
Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H
Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863
[TBL] [Abstract][Full Text] [Related]
44. Aprotinin has direct platelet protective properties: fact or fiction?
Shore-Lesserson L
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):379-81. PubMed ID: 10468247
[No Abstract] [Full Text] [Related]
45. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.
Blauhut B; Harringer W; Bettelheim P; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1083-91. PubMed ID: 7527112
[TBL] [Abstract][Full Text] [Related]
47. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
48. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
49. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
[TBL] [Abstract][Full Text] [Related]
50. Aprotinin reduces the expression of p-selectin on the surface of platelet and leukocyte-platelet conjugates.
Inui K; Shimazaki Y; Watanabe T; Kuraoka S; Uesho K; Uchida T; Shiono S
Artif Organs; 1998 Dec; 22(12):1018-22. PubMed ID: 9876093
[TBL] [Abstract][Full Text] [Related]
51. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
von Segesser LK; Garcia E; Turina MI
Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
[TBL] [Abstract][Full Text] [Related]
52. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery.
Oliver WC; Fass DN; Nuttall GA; Dearani JA; Schrader LM; Schroeder DR; Ereth MH; Puga FJ
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1670-7. PubMed ID: 15173722
[TBL] [Abstract][Full Text] [Related]
53. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
54. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
55. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
56. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass.
Shigeta O; Kojima H; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
Circulation; 1997 Jul; 96(2):569-74. PubMed ID: 9244227
[TBL] [Abstract][Full Text] [Related]
57. Effects of aprotinin on plasma levels of neutrophil elastase and postoperative blood loss in cardiac surgery.
Dernek S; Sevin B; Aslan R; Kaklikkaya I; Atalay C; Kural T
Cardiovasc Surg; 1996 Aug; 4(4):515-9. PubMed ID: 8866093
[TBL] [Abstract][Full Text] [Related]
58. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
Addonizio VP; Fisher CA; Kappa JR; Ellison N
Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
[TBL] [Abstract][Full Text] [Related]
59. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
[TBL] [Abstract][Full Text] [Related]
60. Fresh blood units contain large potent platelets that improve hemostasis after open heart operations.
Mohr R; Goor DA; Yellin A; Moshkovitz Y; Shinfeld A; Martinowitz U
Ann Thorac Surg; 1992 Apr; 53(4):650-4. PubMed ID: 1554276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
